Didier Meulien
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment 11
- Bipolar Disorder and Treatment 4
- Dementia and Cognitive Impairment Research 3
- Epilepsy research and treatment 3
- Pharmacology top 10%
- Treatment of Major Depression 6
-
- Alcoholism and Thiamine Deficiency 3
-
- Substance Abuse Treatment and Outcomes 6
-
- Alcohol Consumption and Health Effects 6
- Co-authors
- Martin BrecherOla SvenssonFrank MillerS. Charles SchulzRené S. KahnEva KohegyiGeorge T. GrossbergRoss A. Baker
- Journals
- European Psychiatry (3 papers)Movement Disorders (2 papers)International Journal of Geriatric Psychiatry (2 papers)
- Partner nations
- United StatesDenmarkSweden
In The Last Decade
Didier Meulien
25 papers receiving 586 citations
Peers
Comparison fields: 5 of 65
- Psychiatry and Mental health 309
- Pharmacology 144
- Biological Psychiatry 21
- Cellular and Molecular Neuroscience 108
- Neurology 74
Countries citing papers authored by Didier Meulien
This map shows the geographic impact of Didier Meulien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Meulien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Meulien more than expected).
Fields of papers citing papers by Didier Meulien
This network shows the impact of papers produced by Didier Meulien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Meulien. The network helps show where Didier Meulien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Didier Meulien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 18 | |
| 4 | 2022 | 29 | |
| 5 | 2019 | 95 | |
| 6 | 2019 | 78 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 15 | |
| 9 | 2017 | 27 | |
| 10 | 2011 | 25 | |
| 11 | 2010 | 20 | |
| 12 | 2009 | 49 | |
| 13 | 2008 | 18 | |
| 14 | 2008 | 1 | |
| 15 | 2007 | 1 | |
| 16 | 2007 | 83 | |
| 17 | Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients. | 2007 | 49 |
| 18 | 2007 | 2 | |
| 19 | 1999 | 41 | |
| 20 | 1997 | 2 |
About Didier Meulien
Didier Meulien is a scholar working on Psychiatry and Mental health, Pharmacology, Pathology and Forensic Medicine, Neurology and Geriatrics and Gerontology, having authored 25 papers that have together received 606 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (11 papers), Substance Abuse Treatment and Outcomes (6 papers), Alcohol Consumption and Health Effects (6 papers), Treatment of Major Depression (6 papers), Bipolar Disorder and Treatment (4 papers), Dementia and Cognitive Impairment Research (3 papers), Alcoholism and Thiamine Deficiency (3 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Psychiatry and Mental health (309 citations), Pharmacology (144 citations), Biological Psychiatry (21 citations), Cellular and Molecular Neuroscience (108 citations) and Neurology (74 citations). Didier Meulien has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Martin Brecher, Ola Svensson, Frank Miller, S. Charles Schulz, René S. Kahn, Eva Kohegyi, George T. Grossberg, Ross A. Baker, Mary Hobart and Robert D. McQuade. Their work appears in journals such as European Psychiatry, Movement Disorders, International Journal of Geriatric Psychiatry, Schizophrenia Research and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.